than 200 papers including several superb reviews and text book chapters.
the cumulus cells provide metabolites, meiotic regulatory factors, and embryonic developmental competence to oocytes. This groundbreaking original concept and the vast body of research work he generated were published in very high impact journals including Nature, Science, PNAS, and Development.
Finally, Dr. Eppig was the Principal Investigator of a Program Project with Drs. Mary Ann Handel and John Schimenti and developed mouse models of infertility using N-ethyl-N-nitrosourea (ENU) mutagenesis. This massive undertaking resulted in numerous discoveries and led to uncovering both novel genes as well as their in vivo biological functions. One of the best examples was the discovery of meiosis regulator and mRNA stability 1, or Marf1, as the meiosis controlling master gene that, besides controlling the progression of meiosis, protects genomic integrity from retrotransposon assault in oocytes. Dr. Eppig and coinvestigators provided various mutants identified in this large-scale ENU genetic screen to investigators around the world to accelerate the mapping and phenotyping of these interesting mutants.
Among the numerous awards Dr. Eppig received include the SSR Research Award, NIH MERIT Award, The Gregor J. Mendel Honorary Medal for Merit in the Biological Sciences awarded by the Academy of Sciences of the Czech Republic, Marine Biology Laboratories Pioneer in Reproduction Research Award, and the SSR Carl G. Hartman Award. In 2011, he was elected as a Member of the National Academy of Sciences (USA). He served on several grant review and advisory panels of academic institutes and as a Vice Chair and Chair of Gordon Conference on Mammalian Gametogenesis and Embryogenesis, and as the 1999-2000, President of the SSR. Between 2004 and 2009, he was Co-Editor-in-Chief, with Dr. Mary Ann Handel, of the Biology of Reproduction (BOR), and since 2012, he continues to serve as an Editorial Board Member of the Proceedings of the National Academy of Sciences (USA). During their tenure as BOR Co-Editors-in-Chief, Drs. Eppig and Handel emphasized scientific excellence and introduced use of correct gene nomenclature in all papers published in BOR to ensure that the work would become recognized and end up in the gene nomenclature driven databases that augment so much research.
In Dr. Eppig's own words "although retirement is not as much fun as doing active research, I've spent my time in retirement organizing meetings, reviewing papers, undertaking various tasks for the National Academy of Sciences, encouraging young scientists, providing unsolicited advice to anyone who will listen, and other more typical retirement things. I do not miss committee meetings or writing research grants". Dr. Eppig kindly agreed to do this interview for Biology of Reproduction.
As a middle-school student, you were fascinated by growth kinetics of protozoans, then studied amphibian metamorphosis, and finally devoted most of your career to studying oocytes-follicles-ovarian biology. How did these topics appeal to you at each phase of your phenomenal career?
My grandfather, who was a biochemist, gave me a really good microscope when I was in high school and I bought a book to help me identify crazy critters that lived in the ponds and puddles near our house. I kept samples in jars every nook and cranny in my room because I was curious to see if different conditions like light or dark or dead leaves or veggies scraped off my dinner plate would affect their populations. It was really great fun but, perhaps best of all, my hobby horrified the rest of my family. One day I came home from school and all the jars had disappeared. Fortunately, my experimental urges did not. When I was older, I was curious about the various amphibians that also lived in the ponds and streams around our house and was amazed by their dramatic development. In college, I decided to study these amazing changes in graduate school, but the wonderful Professor W. Gardner Lynn who recruited me to study metamorphosis instead got me more interested in the formation of melanin pigment and their origins in developing tadpoles and salamanders and this became the subject of my Ph.D. research. I loved collecting the amphibians from the flooded strip mines of the Cumberland Mountains in Tennessee. I'm truly lucky to have emerged from that treacherous experience both alive and with publications. When I became a post-doc in a different lab at Oak Ridge, my new mentor, Jim Dumont, got me interested in the melanin pigments that formed in amphibian eggs; their structure and development are quite different from those that develop in skin or eyes. This was pretty interesting, but I soon became much more infatuated with the entire process of amphibian oogenesis than just the production of melanosomes. After spending 3 years at Brooklyn College of the City University of New York continuing my work on Xenopus eggs and developing methods to study them in vitro, I spent a wonderful summer as a Visiting Investigator in the lab of Leroy Stevens, hero of teratoma and stem cell fame, at the Jackson Laboratory (JAX) in Bar Harbor, Maine. I was recruited to join the JAX faculty after that summer. It was a life changing experience in many ways. But perhaps most importantly, at JAX, they study only mice not frogs. "No problem!" I thought. After all, mice are just warm and furry frogs, right? How different could oogenesis be? Wrong! Coming to JAX also gave me the opportunity hang around people who knew genetics and learn how to use it.
What motivated you to study mammalian oocyte/ovarian biology for such a long time?
I was lucky to get away with it.
From Oak Ridge, Tennessee, to New York City and then to Jackson Lab, Bar Harbor, ME-you have had a remarkable long academic journey. What attracted you to move to Jackson Lab? At that time, were there any investigators interested in oocyte/ovarian biology at Jackson Lab? I wanted to devote 100% of my effort to research with no requirements for teaching classes. The downside of this was that, at the time, a faculty position at JAX was 100% "soft" money. Nevertheless, I took a chance that I could make it work, and it did until I retired in 2013. It was great to have outstanding colleagues here who were eager to help and who are internationally recognized for their achievements such as Eva Eicher (sex determination), Wes Whitten (preimplantation embryo development), Peter Hoppe (in vitro fertilization and embryo manipulation), Leroy Stevens (teratomas and stem cells), Charity Weymouth (somatic cell culture and media development), and Wes Beamer (ovarian cancer). Wes and Peter taught me about the conditions needed for mouse IVF and preimplantation embryo development, particularly unrestrained paranoia, the purity of components, and attention to details; all were key for me to establish oocyte culture conditions. Although not a reproductive biologist, Doug Coleman, whose lab was next to mine, was incredibly generous with his expertise in analytical biochemistry to help with our studies on follicular factors that participate in the maintenance of oocyte meiotic arrest.
What led you to perform in vitro reconstitution experiments using ovarian somatic cells and oocytes?
Frankenovaries! We did not use this term publicly, but only in the lab. It's how we referred to reconstituted chimeric ovaries in which we exchanged the somatic cells and germ cells. So, the Frankenovaries consisted entirely of germ cells of one genotype and a somatic ovarian environment of an entirely different genotype. Our first application of this technology concerned the unusual oocytes of LT/Sv and related mouse strains, which become arrested at metaphase 1 and then often undergo spontaneous parthenogenetic activation. Our question was whether this condition arose because of a defect in LT oocytes or in the somatic environment. To test this, we adapted a strategy originally used by Wai Sum O and Terry Baker in 1978 to exchange male and female fetal germ and somatic cells. Viable somatic cells attach rather tightly to a tissue culture dish but germ cells do not. Thus, differential adhesion could be used to cleanly separate germ cells from somatic cells. Our Frankenovaries were grafted beneath the kidney capsule of ovariectomized immunocompromised mice for development. In addition to using this strategy to assess the relative roles of oocytes and somatic cells derived from different mouse genotypes, we also used it to evaluate the role of oocytes on the rate of follicular growth and interspecies oocytesomatic cell interactions. Yup, we exchanged the oocytes and somatic cells of mice and rats and it worked! In addition, we thought that there would be natural justice to make Frankenovaries using feline and mouse cells but could not claw enough cat material from the local vet.
How did you perfect the in vitro culture conditions for initiation of primordial follicle development and oocyte growth all the way to acquiring meiotic competence and maturation?
It required the expertise of dedicated Research Assistants, particularly Marilyn O'Brien and Karen Wigglesworth, over many years. Also, we realized that a crucial characteristic of a culture system able to support normal oocyte development had to encourage the happiness and function of both the oocytes and their companion granulosa cells and enable the essential conversations between the heterologous cell types.
Your concept of bidirectional communication between the oocyte and companion granulosa cells is regarded as a major advancement in ovarian biology. What led to you undertake this groundbreaking research?
In the late 1970s, my early days at JAX, I began work to establish systems for mouse oocyte development in vitro. My first results showed that granulosa cell-denuded oocytes from preantral follicles could not be persuaded to grow in culture. Oocyte growth was absolutely dependent upon direct contact that maintained metabolic cooperativity with companion granulosa cells. These were the first studies showing mammalian oocyte growth and development in vitro and established a functional relationship between oocytes and granulosa cells that was suggested by the classic early ultrastructural studies of David Albertini and Everett Anderson and the ionic coupling experiments of Bernie Gilula and others. Now we know that the conversations between oocytes and granulosa cells are bidirectional and that signals in both directions are required for the coordinated development and functions of both cell types. Paracrine and juxtacrine pathways are involved and mutually supportive. Female fertility is dependent upon these complex interactions and, no doubt, new modalities for the interdependence await discovery. It's a great time for advanced eavesdropping!
How did you get into developing the massive ENU mutagenesis screens and generating mouse models of infertility?
ENU mutagenesis is an unbiased approach to gene discovery that was being used in several labs at JAX and elsewhere. Essentially, ENU is used to randomly mutate genes, then offspring are screened for phenotypes of interest, then genes are mapped and changes in sequence are identified. John Schimenti, who was then at JAX, embarked upon a small mutagenesis project with an interest in several different phenotypes including those essential for meiosis. He recruited Mary Ann Handel and myself to look at a few interesting infertile strains that he produced and the rest is history. So, credit to John Schimenti for initiating the collaborative ReproGenetics Program Project. I must admit that I was somewhat hesitant about the project at the beginning, but fortunately, I was convinced by my wiser colleagues. I'm glad that they did! At the early stage of this program, Mary Ann Handel was still at the University of Tennessee with designs on coming to JAX upon "retirement." As it turned out, she resumed her great career at JAX and John Schimenti migrated to Cornell University. Nevertheless, the ReproGenomics Program Project grew, with support from the NICHD, and identified many important new mutations affecting fertility. The random mutagenesis approach eventually fell into general disfavor because of the growing ease of targeting specific genes (i.e. knockouts) to determine their function(s), and ENU projects required laborious gene mapping. Methods for economical rapid gene sequencing that are available now would have made the ENU mutagenesis approach much more efficient and a viable modus operandi for discovering unsuspected genes needed for fertility.
From your mutagenesis screens, you discovered that Marf1 is a master regulator of meiosis and protector of genome integrity by retrotransposon attack. Were there any other interesting mutants that you characterized and pursued further?
Marf1 was actually the only female mutant that we followed up on extensively. My former Research Associate You-Qiang Su continues to work on this exciting mutant. The ReproGenomics Project produced many mutants that cause infertility in males, or in both sexes. If you are interested in following up on mutations produced by this Program, I recommend "Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". Biol Reprod. 99:1119 Reprod. 99: -1128 Reprod. 99: (2018 by Mary Ann Handel and John Schimenti.
Sailing in the Atlantic ocean is a passionate hobby of yours. I also know you love to experiment in the kitchen. I remember suggesting you some Indian spices to try in your cooking. Do you still continue these hobbies?
The sun has set on my sailing ventures and I am reluctantly becalmed. However, I continue to experiment in the kitchen without inflicting permanent damage on anyone (that I know of).
